Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening
Open Access
- 12 April 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 92 (9), 1800-1802
- https://doi.org/10.1038/sj.bjc.6602541
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohortBritish Journal of Cancer, 2004
- Cervical cancer screening programmes and policies in 18 European countriesBritish Journal of Cancer, 2004
- The predicted effect of changes in cervical screening practice in the UK: results from a modelling studyBritish Journal of Cancer, 2004
- Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesionsBritish Journal of Cancer, 2004
- The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996Journal of Clinical Pathology, 2004
- Management of women who test positive for high-risk types of human papillomavirus: the HART studyThe Lancet, 2003
- Baseline Cytology, Human Papillomavirus Testing, and Risk for Cervical Neoplasia: A 10-Year Cohort AnalysisJNCI Journal of the National Cancer Institute, 2003
- Women who participate in spontaneous screening are not at higher risk for cervical cancer than women who attend programme screeningEuropean Journal Of Cancer, 2002
- PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changesJournal of Clinical Pathology, 2000
- Assessing gains in diagnostic utility when human papillomavirus testing is used as an adjunct to Papanicolaou smear in the triage of women with cervical cytologic abnormalitiesAmerican Journal of Obstetrics and Gynecology, 1999